Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 14/20 | 0.59 |
| ▸ | LPL | P06858 | 13/20 | 0.59 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
| ▸ | F11 | P03951 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.40 |
| ▸ | P4HB | P07237 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL806784 | 0.89 | LIPG (0.60) | LIPGLPLIRAK4CA1CA2 | |
| SCHEMBL3429762 | 0.87 | LIPG (0.53) | LIPGLPLIRAK4CA1CA2 | |
| SCHEMBL20023287 | 0.87 | LIPG (0.58) | LIPGLPLIRAK4CA1CA2 | |
| SCHEMBL29591441 | 0.87 | LIPG (0.53) | LIPGLPLIRAK4CA1CA2 | |
| SCHEMBL31456342 | 0.87 | LIPG (0.58) | LIPGLPLIRAK4CA1CA2 | |
| SCHEMBL5892478 | 0.87 | LIPG (0.53) | LIPGLPLIRAK4CA1CA2 | |
| SCHEMBL31456345 | 0.87 | LIPG (0.58) | LIPGLPLIRAK4CA1CA2 | |
| SCHEMBL3429760 | 0.86 | LIPG (0.51) | LIPGLPLIRAK4CA1CA2 | |
| SCHEMBL18712525 | 0.86 | LIPG (0.51) | LIPGLPLIRAK4CA1CA2 | |
| SCHEMBL103840 | 0.86 | LIPG (0.51) | LIPGLPLIRAK4CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 248 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4709720-A1 | INHIBITORS AND DEGRADERS OF PIP4K PROTEIN | Larkspur Biosciences, Inc. (US) | 2026-03-18 | — | — | EP | disclosed |
| US-12538704-B2 | 4H-imidazo[1,2-a]imidazoles for electronic applications | UDC IRELAND LIMITED (IE) | 2026-01-27 | — | — | US | disclosed |
| WO-2025073290-A1 | VPS4 INHIBITORS AND METHODS OF USE THEREOF | PARA THERAPEUTICS, INC. (US) | 2025-04-10 | — | — | WO | disclosed |
| US-12268086-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2025-04-01 | — | — | US | disclosed |
| WO-2025040549-A1 | NOVEL AROMATIC COPOLYMER COMPRISING SULFONATE-SUBSTITUTED NAPHTHALENE REPEAT UNITS AND AROMATIC PHENYL, BIPHENYL OR TERPHENYL REPEAT UNITS, AND THE PRODUCTION AND USE THEREOF | Technische Universität Chemnitz, Körperschaft des öffentlichen Rechts (DE) | 2025-02-27 | — | — | WO | disclosed |
| WO-2025023701-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 주식회사 진웅산업 | 2025-01-30 | — | — | WO | disclosed |
| WO-2024258160-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 진웅산업 | 2024-12-19 | — | — | WO | disclosed |
| WO-2024233846-A1 | INHIBITORS AND DEGRADERS OF PIP4K PROTEIN | LARKSPUR BIOSCIENCES, INC. (US) | 2024-11-14 | — | — | WO | disclosed |
| US-20240292743-A1 | LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-08-29 | — | — | US | disclosed |
| US-20240270725-A1 | MAGL INHIBITORS | HOFFMANN-LA ROCHE INC. (US) | 2024-08-15 | — | — | US | disclosed |
| US-20070088130-A1 | Conformationally Flexible Cationic Conjugated Polymers | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-04-19 | — | — | US | disclosed |
| US-20070088130-A1 | Conformationally Flexible Cationic Conjugated Polymers | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-04-19 | — | — | US | disclosed |
| US-20070088130-A1 | Conformationally Flexible Cationic Conjugated Polymers | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-04-19 | — | — | US | disclosed |
| US-7144950-B2 | Conformationally flexible cationic conjugated polymers | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-12-05 | — | — | US | disclosed |
| EP-1673410-A2 | CONFORMATIONALLY FLEXIBLE CATIONIC CONJUGATED POLYMERS | The Regents of the University of California (US) | 2006-06-28 | — | — | EP | disclosed |
| WO-2005086617-A2 | CONFORMATIONALLY FLEXIBLE CATIONIC CONJUGATED POLYMERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-09-22 | — | — | WO | disclosed |
| US-20050203308-A1 | Catalytic boronate ester synthesis from boron reagents and hydrocarbons | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2005-09-15 | — | — | US | disclosed |
| US-6878830-B2 | Catalytic boronate ester synthesis from boron reagents and hydrocarbons | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2005-04-12 | — | — | US | disclosed |
| US-20050059168-A1 | Conformationally flexible cationic conjugated polymers | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-03-17 | — | — | US | disclosed |
| US-20030109380-A1 | Catalytic boronate ester synthesis from boron reagents and hydrocarbons | BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY (US) | 2003-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12538704-B2 | 4H-imidazo[1,2-a]imidazoles for electronic applications | RIF1, NR2E1, NR3C1 | LIPG 4484/4885LPL 4437/4885IRAK4 2263/4885 |
| US-12268086-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | PIEZO1, OCIAD1, LEF1 | LIPG 1295/4885LPL 2598/4885IRAK4 1371/4885 |
| US-20240270725-A1 | MAGL INHIBITORS | MGLL, PNLIP, LPL | LIPG 12/4885LPL 3/4885IRAK4 3665/4885 |
| US-20050203308-A1 | Catalytic boronate ester synthesis from boron reagents and hydrocarbons | HBB, BTD, HMBS | LIPG 2509/4885LPL 2647/4885IRAK4 3696/4885 |
| US-20030109380-A1 | Catalytic boronate ester synthesis from boron reagents and hydrocarbons | HBB, BTD, HMBS | LIPG 2509/4885LPL 2647/4885IRAK4 3696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.